Implication of the non-canonical Wnt pathway in neural tube defects
- Arturo Amarilla Gudiño
- José Manuel Caro Vega
- Patricia Ybot González
ISSN: 2254-3821
Año de publicación: 2017
Número: 6
Tipo: Artículo
Otras publicaciones en: Biosaia: Revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria
Referencias bibliográficas
- Kibar Z., Salem S., Bosoi C.M., Pauwels E., De Marco P., Merello E., Bassuk A.G., Capra V., Gros P. (2011)Contribution of VANGL2 mutations to isolated neural tube defects.Clin Genet 80:76-82.
- Sarris C.E., Tomei K.L., Carmel P.W., Gandhi C.D. (2012)Lipomyelomeningocele: pathology, treatment, and outcomes. Neurosurg Focus 33:E3.
- Wallingford J.B., Niswander L.A., Shaw G.M., Finnell R.H.(2013)The continuing challenge of understanding, preventing, and treating neural tube defects. Science 339:1222002.
- Ybot-Gonzalez, P., Savery, D., Gerrelli, D., Signore, M., Mitchell, C.E., Faux, C.H., Greene, N.D.E., Copp, A.J. (2007) Convergentextension, planar cell polarity signalling and initiation of mouse neural tube closure. Development 134(4):789-799.